Evaluation of FDA safety-related drug label changes in 2010-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Evaluation of FDA safety-related drug label changes in 2010

Published:2013-01-02 Issue:3 Volume:22 Page:302-305
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Lester Jean¹²,Neyarapally George A.²,Lipowski Earlene¹,Graham Cheryl Fossum²,Hall Marni²,Dal Pan Gerald²

Affiliation:

1. University of Florida College of Pharmacy; Department of Pharmaceutical Outcomes and Policy; 1225 Center Drive, HPNP 3334 Gainesville FL 32611 USA

2. Food and Drug Administration; Center for Drug Evaluation and Research; 10903 New Hampshire Avenue Silver Spring MD 20993 USA

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pds.3395/fullpdf

Reference11 articles.

1. Role of postmarketing surveillance in contemporary medicine;Woodcock;Annu Rev Med,2011

2. MedWatch. The FDA safety information and adverse event reporting program safety information http://www.fda.gov/Safety/MedWatch/default.htm 2011

3. Document Archiving 2011

4. Bartholow M Top 200 Drugs of 2010 http://www.pharmacytimes.com/publications/issue/2011/May2011/Top-200-Drugs-of-2010 2012

5. Sources of post-market drug safety issues: an analysis of FDA drug safety communications;Ishiguro;Pharmacoepidemiol Drug Saf,2012

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A systematic analysis and data mining of opioid-related adverse events submitted to the FAERS database;Experimental Biology and Medicine;2023-12-30

2. Appeal for Increasing the Impact of Pharmacovigilance;Drug Safety;2023-12-20

3. Safety profile and signal detection of phosphodiesterase type 5 inhibitors for erectile dysfunction: a Food and Drug Administration Adverse Event Reporting System analysis;Sexual Medicine;2023-10-01

4. Characterization of Pediatric Reports in the US Food and Drug Administration Adverse Event Reporting System from 2010–2020: A Cross-Sectional Study;Therapeutic Innovation & Regulatory Science;2023-06-23

5. Profile of adverse drug reaction reports in South Africa: An analysis of VigiBase® for the year 2017;South African Medical Journal;2023-06-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3